Back to search

Article

Structural basis of insulin receptor antagonism by bivalent site 1-site 2 ligands

2025-08-24

Abstract excerpt

<h4>ABSTRACT</h4> Congenital hyperinsulinism (HI) is a rare genetic disease characterized by overproduction of insulin. One class of potential HI treatments is insulin receptor (IR) antagonists like S961 and Ins-AC-S2, peptides composed of binding segments for each of the IR sites capable of binding insulin: site 1 and site 2. Notably, S597 – containing the same IR binding segments as S961 but in the opposite ord...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2378d4ec-8c66-58c2-b885-a9cc71c11f30
DOI
10.1101/2025.08.23.671589
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Structural basis of insulin receptor antagonism by bivalent site 1-site 2 ligandsDOI 10.1101/2025.08.23.671589
Select a neighboring publication to make it the new centre.